MRI瘤内异质性量化鉴别胶质母细胞瘤与单发脑转移瘤
本回顾性两中心研究纳入355例胶质母细胞瘤或单发脑转移瘤患者的增强T1WI数据,利用2.5D数据整合局部影像组学特征与全局像素分布模式计算ITH评分。内部测试中ITH模型AUC为0.82,联合模型AUC为0.90,外部测试中分别为0.81与0.87,校准曲线与决策曲线分析证实联合模型具有良好校准能力与临床适用性。
要点
- 增强T1WI的瘤内异质性量化模型在两个中心均明显优于常规影像组学模型
- 联合影像组学与ITH模型AUC最高,对术前鉴别诊断最具参考价值
- 基于2.5D数据整合局部与全局特征的方法可用于无创辅助胶质母细胞瘤与单发脑转移瘤鉴别
核心结论
- MRI-based quantification of intratumoral heterogeneity may serve as an effective noninvasive tool for differentiating glioblastoma from solitary brain metastasis
- The combined radiomics-ITH model achieved the best predictive performance, with an AUC of 0.90 in internal test and 0.87 in external test
研究设计与样本
- 回顾性两中心研究,纳入355例经病理诊断为胶质母细胞瘤或单发脑转移瘤的患者
- Institution 1(n=267)用于预测模型开发并作为内部测试集,Institution 2(n=88)作为外部测试集
- 影像数据使用对比增强T1加权成像(CE-T1WI),基于2.5D数据计算ITH评分
关键影像表现/征象
- 增强T1WI所示肿瘤内部的局部影像组学特征与全局像素分布模式共同构成瘤内异质性量化基础
- 瘤内异质性程度在胶质母细胞瘤与单发脑转移瘤之间存在可量化的影像差异
诊断标准与关键数值
- ITH模型内部测试AUC为0.82,外部测试AUC为0.81,显著优于影像组学模型
- 影像组学模型内部测试AUC为0.64,外部测试AUC为0.62
- 联合模型内部测试AUC为0.90,外部测试AUC为0.87
- 校准曲线与决策曲线分析证实联合模型具备良好校准能力与临床适用性
临床应用与阅片要点
- 对幕上单发强化病灶,增强T1WI瘤内异质性量化可作为胶质母细胞瘤与单发脑转移瘤鉴别的无创辅助手段
- 临床决策困难时可优先参考联合影像组学与ITH模型的结果,而非单独使用常规影像组学模型
局限性
- 回顾性研究设计、两中心样本量有限,仅使用增强T1WI序列而未纳入其他功能或结构序列
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the value of MRI-based quantification of Intratumoral Heterogeneity (ITH) for differentiating Glioblastoma (GBM) from Solitary Brain Metastasis (SBM).
METHODS: This retrospective study included contrast-enhanced T1-weighted imaging (CE-T1WI) data from 355 patients diagnosed with GBM or SBM at two institutions. Data from Institution 1 (n = 267) were used for predictive model development and as an internal test dataset, while data from Institution 2 (n = 88) constitute the external test dataset. To quantify ITH, 2.5D data were utilized to calculate the ITH-scores by integrating local radiomics features and global pixel distribution patterns, and the ITH model was constructed on this basis. Moreover, a radiomics model and a combined radiomics-ITH model were established. The predictive performance of three models was comprehensively evaluated using calibration curves, decision curve analysis (DCA), accuracy, and AUC.
RESULTS: The radiomics model achieved an AUC of 0.64 in internal test dataset and 0.62 in external test dataset, whereas the ITH model yielded an AUC of 0.82 in internal test dataset and 0.81 in external test dataset, the ITH model exhibited significantly better predictive performance than the radiomics model. The predictive efficacy of the combined radiomics-ITH model was further improved, with an AUC of 0.90 in internal test dataset and 0.87 in external test dataset. Calibration curves and DCA confirmed the combined model possessed favorable calibration ability and good clinical applicability.
CONCLUSIONS: MRI-based quantification of ITH may serve as an effective noninvasive tool for differentiating GBM from SBM and assist in clinical decision-making.
引用
- Zhu, Li, Li, et al. MRI-based quantification of intratumoral heterogeneity for differentiating glioblastoma from solitary brain metastasis: a two-center study. Eur J Radiol. 2026. PMID: 42401075. doi:10.1016/j.ejrad.2026.113045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。